Alpha-1 Antitrypsin Deficiency (A1-Antitrypsin Deficiency, A1AD) is a genetic disorder that causes defective production of Alpha-1 Antitrypsin (A1AT), leading to decreased A1AT activity in the blood and lungs, and deposition of excessive abnormal A1AT protein in liver cells.
Alpha-1 Canada’s mission is to provide information, education and support to Canadians affected by Alpha-1 Antitrypsin Deficiency; inform and educate the medical community about Alpha-1 Antitrypsin Deficiency; and generate broad awareness about this genetic liver, lung and skin disease.
Plasma donation is critically important and contributes to saving lives. Your plasma will be used to create therapies that treat a variety of conditions and diseases, such as Alpha-1 Antitrypsin Deficiency. To locate a plasma donation clinic near you please visit www.blood.ca/en/blood/about-plasma or www.hema-quebec.qc.ca